Virological Response

Experimental HBV Drug Pradefovir: Safety, Tolerability, Antiviral Activity, and Pharmacokinetics - 11/21/05

Lamivudine Effectively Reduces HBV Viral Load in HBeAg-negative Patients 9/29/04

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 
 

HIV AND AIDS | HEPATITIS B | HEPATITIS C | HIV / HBV CO-INFECTION | HIV / HCV CO-INFECTION | HEALTH AND TECHNOLOGY | TESTS |
INTERNET CONFERENCE REPORTS | LINKS | ABOUT US | CONTACT US